N@N

Finkelstein Thompson LLP Announces Investigation of SRA International, Inc.

_{//science-technology.news-articles.net/content/2 .. nces-investigation-of-sra-international-inc.html}
^{Published in Science and Technology on Friday, April 1st 2011 at 18:40 GMT by Market Wire}  

WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of SRA International, Inc. (aSRAa or the aCompanya) (NYSE: SRX) concerning the proposed acquisition of the Company by the private equity firm Providence Equity Partners. Under the terms of the offer, SRA common shareholders will receive $31.25 in cash for each share they own in a transaction valued at approximately $1.88 billion.

The investigation is focused on the potential unfairness of the consideration to SRA shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among SRA Board members. The offer price is only a 10% premium above the Companya™s trading price the day before the announcement. Moreover, SRAa™s Chairman and founder, Ernest Volgneau, who will continue as Chairman following the merger, has a 71% voting stake in the Company, and has already agreed to vote his shares in favor of the merger.

If you are interested in discussing your rights as an SRA shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.